Founded Year

2009

Stage

Private Equity | Alive

Total Raised

$300M

Valuation

$0000 

Last Raised

$300M | 3 yrs ago

About Equashield

Equashield is a medical device company that specializes in the development and provision of Closed System Transfer Devices (CSTDs). The company's main offerings include a range of products designed for the safe handling of hazardous drugs, from the compounding process in pharmacies to administration in nursing settings. These products, which include closed syringes, adapters, connectors, and tubing sets, aim to protect healthcare workers from exposure to hazardous drugs and vapors. It was founded in 2009 and is based in Port Washington, New York.

Headquarters Location

2 Harbor Park Drive

Port Washington, New York, 11050,

United States

516-684-8200

Loading...

Loading...

Expert Collections containing Equashield

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Equashield is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,270 items

Equashield Patents

Equashield has filed 41 patents.

The 3 most popular patent topics include:

  • fluid dynamics
  • robotic manipulators
  • surgery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/22/2024

12/17/2024

Wind turbines, Vertical axis wind turbines, Fluid dynamics, Statistical charts and diagrams, Elementary mathematics

Grant

Application Date

2/22/2024

Grant Date

12/17/2024

Title

Related Topics

Wind turbines, Vertical axis wind turbines, Fluid dynamics, Statistical charts and diagrams, Elementary mathematics

Status

Grant

Latest Equashield News

08:55 ET EQUASHIELD® and Pharmacy Stars Forge Strategic Partnership to Elevate Safety and Compliance in Healthcare

Dec 3, 2024

News provided by Share this article Share toX PORT WASHINGTON, N.Y., Dec. 3, 2024 /PRNewswire/ -- EQUASHIELD®, a leader in protecting healthcare workers through innovative compounding solutions and their closed system transfer device (CSTD), is proud to announce a strategic partnership with Pharmacy Stars, the premier provider of a cloud-based platform for pharmacy compliance. This collaboration aims to significantly enhance safety standards and compliance across healthcare systems nationwide, optimizing pharmacy operations with progressive technology and expertise. Committed to Excellence: EQUASHIELD and Pharmacy Stars Team Up to Enhance Safety and Compliance in Healthcare EQUASHIELD® is renowned for its industry-leading CSTD, featuring the only closed-back Syringe Unit on the market, a sophisticated safety mechanism designed to prevent contamination and vapor escape during the handling of hazardous drugs. Notably, EQUASHIELD®'s Mundus Mini HD leverages their proven CSTD alongside automation to shield healthcare professionals from hazardous drug exposure, reinforcing comprehensive safety measures. Their advanced systems protect healthcare professionals, ensuring a safer working environment. The EQUASHIELD® Syringe Unit is equipped with a unique dual-needle, air-to-liquid exchange system that maintains pressure equalization, effectively protecting against the escape of hazardous vapors and aerosols. Pharmacy Stars complements this expertise with its groundbreaking cloud-based platform, Compounding360, which streamlines pharmacy regulatory compliance. Loaded with industry expert SOPs, the Compounding360 platform is the only quality management system (QMS) that puts everything in one place, including expert training and a learning management system, ensuring efficient standardization and centralized management of compounding compliance with USP and NAPRA standards. The integration of EQUASHIELD®'s technology with Pharmacy Stars' Compounding360 system brings a multitude of benefits, including: Enhanced Training and Compliance: Meeting USP 797 standards, personnel will have access to continuously updated CSTD training year-round, with microlearning formats and competency quizzes readily available to ensure staff compliance. Comprehensive Safety Measures: By combining EQUASHIELD®'s proven CSTD with Pharmacy Stars' compliance tools, the partnership provides unmatched protection and standardization for healthcare workers handling hazardous drugs. "This partnership represents a significant step forward in our commitment to protecting healthcare environments," said Armando Radelat, General Manager of EQUASHIELD® Compounding Technologies. "By joining forces with Pharmacy Stars, we are not only enhancing safety measures but also ensuring regulatory compliance and operational efficiency across health systems." Pharmacy Stars CEO, Keith Streckenbach, added, "Our collaboration with EQUASHIELD® underlines our dedication to pioneering solutions that drive compliance and safety in pharmacy operations. Together, we are setting new benchmarks for the industry." This strategic alliance marks a new era in healthcare safety and compliance, promising to deliver unparalleled value to industry professionals and stakeholders. As the healthcare landscape evolves, EQUASHIELD® and Pharmacy Stars remain at the forefront, committed to excellence and innovation in pharmacy operations. About EQUASHIELD® Established in 2009, EQUASHIELD® Compounding Technologies is a globally recognized leading provider of manual and automated solutions for compounding and administration, committed to safeguarding healthcare professionals from exposure to hazardous drugs while increasing efficiency. EQUASHIELD®'s product suite includes its flagship CSTD and the Mundus Mini HD, a groundbreaker in safe automated compounding of hazardous drugs. EQUASHIELD® CSTD is FDA cleared for preventing microbial ingress for up to seven days and for full volume use of the Syringe Unit. Together the EQUASHIELD® CSTD and Mundus Mini HD redefine handling hazardous drugs, reducing the risk of exposure to hazardous drugs and simplifying workflows. For more information about EQUASHIELD® and its solutions, visit [ www.equashield.com ] For Media Inquiries:

Equashield Frequently Asked Questions (FAQ)

  • When was Equashield founded?

    Equashield was founded in 2009.

  • Where is Equashield's headquarters?

    Equashield's headquarters is located at 2 Harbor Park Drive, Port Washington.

  • What is Equashield's latest funding round?

    Equashield's latest funding round is Private Equity.

  • How much did Equashield raise?

    Equashield raised a total of $300M.

  • Who are the investors of Equashield?

    Investors of Equashield include Nordic Capital.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.